This information sheet was prepared by the research team at the University of Tasmania, taking into account input from a range of stakeholders. Pending the issuing of an APVMA permit for Bravecto¬¨vÜ, the purpose of this sheet is to assist treaters and veterinarians who have chosen to use Bravecto¬¨vÜ by providing them with up-to-date information that is based on the best available evidence from current research. As such, the information provided within is an accurate representation of what is presently known and not known regarding the use of fluralaner to treat sarcoptic mange in wombats. This information sheet will be updated as knowledge grows through scientific research and field experience (see page footer for the location of the most up-to-date version).